There are several reasons why a person might need ketamine treatment, including treatment-resistant depression, anxiety, PTSD, chronic pain, bipolar disorder, obsessive compulsive disorder (OCD), and related addiction. Find out if it’s right for you.
Key Takeaways
- Ketamine was once mainly used as an analgesic and anesthetic in medical settings, but is now becoming a popular choice for treating mental health conditions.
- Though mainly known for treating treatment-resistant depression, it may also treat PTSD, OCD, anxiety, chronic pain, bipolar depression, and addiction.
- While effective, ketamine should always be administered in a medically supervised setting and after a careful evaluation process.
Table of Contents
- What is Ketamine Therapy?
- Who Is (And Isn’t) a Good Candidate for Ketamine Therapy?
- What Are Seven Reasons People Seek Ketamine Therapy?
- How Do I Know If Ketamine Is Right For Me?
- BNI Provides Treatment for Optimal Mental Well-Being
- FAQs
Introduction
Ketamine therapy is an innovative modality for treating treatment-resistant depression and other mental and physical health conditions. Originally an anesthetic, it has emerged as a solution for individuals who have experienced minimal success with conventional mental health treatments, such as therapy and medications. A five-year real-world study reveals 55% of people responded successfully to treatment.

Considering the many conditions ketamine therapy can treat, you may wonder if it’s right for you. This article will review who it’s for and why.
What is Ketamine Therapy?
Ketamine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, meaning it blocks a specific type of receptor involved in glutamate neurotransmission. Glutamate is the brain’s primary excitatory neurotransmitter and plays a key role in mood regulation, pain processing, learning, and neuroplasticity, the brain’s ability to form and reorganize connections.
When comparing ketamine therapy vs traditional antidepressants, conventional medications target serotonin and dopamine and take weeks or months to produce results; ketamine works quickly, providing results within hours or days rather than months. The rapid onset is one of its biggest benefits, especially for individuals in acute distress.
Ketamine therapy can be administered as follows:
- Ketamine Infusion Therapy: IV ketamine therapy is administered in a clinical setting
- Nasal Spray: Spravato is an FDA-approved ketamine nasal spray also administered through outpatient treatments
- Oral Tablets: These are more accessible and available at a lower price point, but the lack of medical oversight makes them less effective
Who Is (And Isn’t) a Good Candidate for Ketamine Therapy?
Ketamine therapy may be recommended for individuals who have been diagnosed with a condition approved for the treatment, such as treatment-resistant depressive symptoms, post-traumatic stress disorder, PTSD, or chronic pain. It is typically approved after a thorough assessment.
It is not recommended for individuals with the following conditions:
- Active psychosis, schizophrenia, and certain personality disorders: Ketamine’s dissociative effects could worsen psychotic symptoms
- Uncontrolled or untreated mania (bipolar): Risk of triggering or escalating a manic episode
- Uncontrolled hypertension of cardiovascular conditions: Ketamine can raise blood pressure and heart rate
- Active, untreated substance use disorder: Ketamine carries abuse potential, making it risky for individuals with untreated addiction issues
- Pregnancy: Safety data are insufficient
- Those unwilling to commit to the full treatment protocol and follow-up
What Are Seven Reasons People Seek Ketamine Therapy?
While ketamine therapy is mainly used to address treatment-resistant depression, a condition that impacts 30% of the 280 million people diagnosed with depression. However, research indicates that it can also treat other mental and physical health conditions, as follows:
Treatment-Resistant Depression
This condition is generally defined as depression that has not responded to at least two antidepressant medications at adequate doses. Ketamine has been primarily approved for major depressive disorder, but can also be used for bipolar depression, atypical and melancholic depression subtypes, and postpartum depression. There is minimal evidence on its effectiveness in treating persistent depressive disorder, psychotic depression, and mild or moderate depression without treatment resistance.
Ketamine helps treat depression by promoting neuroplasticity, stimulating the growth of synaptic connections impacted by the condition.
Anxiety Disorders
Ketamine is known for its anxiolytic effects. It is thought to help regulate hyperactive fear and response circuitry that underlies many anxiety disorders. The therapy also promotes neuroplasticity, helping complementary therapies take hold more effectively.
Various types of anxiety can be treated with ketamine therapy, providing rapid results.
Post-Traumatic Stress Disorder (PTSD)
Ketamine has been drawing attention as an effective treatment for PTSD due to its ability to disrupt fear memory consolidation. It is thought to interfere with NMDA receptor activity during consolidation, thereby reducing the emotional charge associated with traumatic memories. Currently, it is typically integrated alongside talk therapy, and is not yet incorporated into official ketamine for PTSD treatment guidelines.
Chronic Pain
As an analgesic, ketamine blocks NMDA receptors involved in pain signal processing. It may be effective in reducing pain associated with fibromyalgia, neuropathic pain, and CRPS, especially in treatment-resistant cases. The treatment is also often recommended to individuals who experience chronic pain as a side effect of anxiety or major depression.
Bipolar Depression
This condition is characterized by a combination of depression symptoms and mania or hypermania. Ketamine may help with the depressive symptoms associated with the mental health disorder. However, treatment must be monitored carefully as the medication can also trigger mania or hypermania.
Obsessive Compulsive Disorder (OCD)
Researchers have found that glutamergic dysfunction is a key characteristic of OCD. Therefore, ketamine’s effectiveness as an NMDA receptor antagonist could offer relief for anxiety-related compulsions and the intrusive, unwanted obsessions that drive them.
While promising, research is still emerging concerning ketamine as an OCD treatment. Individuals considering this option should do so under careful medical advisement and with realistic expectations.
Addiction and Substance Abuse
Ketamine is being carefully researched as a potential treatment for addiction and substance abuse, as it impacts the glutamate system, which is involved in cravings, conditioned responses, and reward pathways. Its NMDA receptor antagonism may interrupt neurological patterns that sustain addictive behavior.
However, ketamine can also be addictive, and should only be administered in a medically supervised environment where addictive tendencies are carefully monitored.
How Do I Know If Ketamine Is Right For Me?

Ketamine may be right for you if you’ve received a diagnosis for one of the conditions ketamine addresses, have tried multiple sessions of therapy and traditional medications without success, are medically stable and ready to commit to a treatment plan, and if your mental health condition is significantly impacting your life.
If this describes your situation, speak to your physician and a mental health professional. They will evaluate your situation, considering your medical history, and determine the best path moving forward.
BNI Provides Treatment for Optimal Mental Well-Being
Ketamine therapy has moved well beyond the research stage. There is now substantial and growing evidence supporting its use for treatment-resistant depression, anxiety, PTSD, chronic pain, bipolar depression, OCD, and certain substance use disorders. It represents a meaningful and clinically supported pathway forward for people who have not found relief with traditional treatments.
The most important step is working with a qualified treatment team that can evaluate whether ketamine therapy is appropriate for your specific situation, administer it safely, and integrate it into a broader care plan designed for long-term recovery and well-being.
If you or someone you love is struggling with a condition that hasn’t responded to traditional treatment, BNI Clinics in Los Angeles offers outpatient ketamine therapy as part of a comprehensive, individualized treatment approach. Contact our team to learn more about whether ketamine therapy may be right for you.
FAQs
How long does ketamine therapy take to work?
A person will feel the effects of ketamine therapy within hours, with gradual improvements over 24 hours. However, follow-up sessions are needed to maintain results.
How many ketamine therapy sessions will I need?
While the number of sessions a person needs varies, most require three weekly sessions across two weeks for a total of six sessions. Follow-up treatments are typically needed and may occur once every two weeks.
Is ketamine therapy safe?
Ketamine therapy is safe when medically supervised and administered for the appropriate conditions. However, side effects may occur, including dissociative effects, temporary increases in heart rate and blood pressure, nausea, vomiting, mild perceptual changes, headache, and fatigue.
Is ketamine therapy covered by insurance?
Individuals considering treatment may wonder about ketamine therapy cost and whether it’s covered by insurance. While expensive, insurance is available, generally for Spravato nasal spray only. Other therapies, such as pills and IV infusions, are not FDA-approved, making them more difficult to obtain coverage for.
Sources
- National Institute of Mental Health / Yavi et al. “Ketamine treatment for depression: a review.” Discover Mental Health, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010394/
- Bratsos S, Saleh SN. “Clinical Efficacy of Ketamine for Treatment-resistant Depression.” Cureus, 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758959/
- Sakopoulos S, Todman M. “The Effects of Psychotherapy on Single and Repeated Ketamine Infusion(s) Therapy for Treatment-Resistant Depression.” International Journal of Molecular Sciences, 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12294355/
- Gutierrez G, Kang MJY, Vazquez G. “IV low dose ketamine infusions for treatment resistant depression: Results from a five-year study at a free public clinic in an academic hospital.” Psychiatry Research, 2024. https://pubmed.ncbi.nlm.nih.gov/38518518/
- Sicignano DJ et al. “The Impact of Ketamine for Treatment of Post-Traumatic Stress Disorder: A Systematic Review With Meta-Analyses.” Annals of Pharmacotherapy, 2024. https://journals.sagepub.com/doi/10.1177/10600280231199666
- Liu JJW et al. “Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review.” Frontiers in Psychiatry, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11228764/
- Batievsky D et al. “Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches.” Frontiers in Pain Research, 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235727/
- “Beyond Anesthesia: Ketamine’s Expanding Role in Chronic Pain and Psychiatric Disorders.” PubMed, 2025. https://pubmed.ncbi.nlm.nih.gov/40767004/
- “Ketamine for Chronic Non-Cancer Pain: A 2023 Update.” NCBI Bookshelf, 2023. https://www.ncbi.nlm.nih.gov/books/NBK599849/
- Glisson A et al. “Ketamine As A New Therapeutic Option For The Management Of Mental Disorders.” PMC, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567721/
- Murrough JW et al. “Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders.” Therapeutic Advances in Psychopharmacology, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8679040/
- Beaglehole B et al. “Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study.” Journal of Psychopharmacology, 2025. https://journals.sagepub.com/doi/10.1177/02698811241301215
- Chambers RA et al. “Ketamine’s Therapeutic Role in Substance Use Disorders: A Narrative Review.” PMC, 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12452417/
- Tran K, MacDougall D. “Ketamine for Adults With Substance Use Disorders.” NCBI Bookshelf / Canadian Agency for Drugs and Technologies in Health, 2024. https://www.ncbi.nlm.nih.gov/books/NBK602506/
Call (310) 691-5005 for a FREE CONSULTATION or fill out our FORM:
General Clinic FAQs
What conditions do BNI Clinics treat?
BNI Clinics evaluate and treat a wide range of neurological and mental health conditions, including anxiety, depression, ADHD, PTSD, memory issues, migraines, sleep disorders, and brain-related performance concerns. Each patient receives a personalized care plan from licensed clinicians.
Who will be assessing or treating me?
All assessments and treatments at BNI Clinics are carried out by qualified, licensed healthcare professionals, including neurologists, psychiatrists, psychologists, and certified therapists. Our team follows evidence-based guidelines and continues to undergo ongoing clinical training.
How does BNI diagnose brain-related conditions?
Diagnosis is done through a structured, clinical process that may include a physical exam, neurological evaluation, mental health screening, cognitive testing, and, when appropriate, advanced diagnostic tools. We use validated, research-backed methods aligned with global clinical standards.
Do I need a referral to visit BNI Clinics?
Most patients do not need a referral. You may schedule an appointment directly. However, some insurance plans may have referral requirements, and our team can guide you based on your coverage.
What happens during my first visit?
Your first appointment includes a detailed consultation with a clinician to review your symptoms, medical history, lifestyle factors, and goals. You will receive a clear explanation of any recommended tests, next steps, and treatment options.
Are the treatments at BNI Clinics evidence-based?
Yes. All therapies, medications, and clinical protocols offered at BNI Clinics follow evidence-based standards, supported by current research, clinical guidelines, and real-world patient outcomes.
Can BNI help if I have already tried treatments elsewhere?
Many patients come to BNI Clinics after trying other providers or treatment options. Our multidisciplinary team can review your past records, reassess your condition, and offer a more comprehensive or targeted care plan.
How long does treatment usually take?
Treatment duration varies based on the condition and severity. Some patients see improvement within weeks, while chronic or complex cases may require longer monitoring. Your clinician will outline a realistic timeline during your consultation.
Is my information kept confidential?
Yes. We follow all required medical privacy regulations, including HIPAA (if US-based). Your personal and medical information is securely stored and never shared without your consent.
Do BNI Clinics support ongoing care and follow-ups?
Yes. After your initial diagnosis and treatment plan, our clinicians schedule regular follow-ups to track progress, adjust treatment, and ensure long-term wellness.



